Befejeződött1. fázis
A study comparing the new drug PG413 produced by Celon Pharma SA with the drug Eliquis available on the market in healthy volunteers.
Key facts
- Where
- Nadarzyn, LengyelországSee the site
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Lengyelország
- BioResearch Group sp. z o.o.Nadarzyn, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Celon Pharma S.A.
- Trial code
- EU 2024-519660-40-00
- Record updated
- 2025. március 27.